UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000005368 |
|---|---|
| Receipt number | R000006369 |
| Scientific Title | Phase II study of a combination of CPT-11 and S-1 and Panitumumab in patients with KRAS wild-type metastatic colon cancer. |
| Date of disclosure of the study information | 2011/04/04 |
| Last modified on | 2019/02/03 21:23:53 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2011/04/02 12:09:32 | ||
| 2 | Update | 2012/10/10 14:34:23 | Recruitment status Publication of results |
|
| 3 | Update | 2012/10/24 10:34:08 | Post marketing survey by drug manufacture etc., specified by Japanese law. Email1 |
|
| 4 | Update | 2012/10/24 10:34:31 | Recruitment status |
|
| 5 | Update | 2013/10/06 11:26:15 | TEL |
|
| 6 | Update | 2014/04/07 23:05:38 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 7 | Update | 2014/10/02 21:59:46 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 8 | Update | 2017/04/06 22:46:52 | Name of primary person or sponsor Organization |
|
| 9 | Update | 2019/02/03 21:23:53 | Recruitment status Publication of results |
